>
Zoetis Inc logo

ZTS - Zoetis Inc Share Price

$159.85 -0.2  -0.1%

Last Trade - 09/04/21

Sector
Healthcare
Size
Large Cap
Market Cap £55.43bn
Enterprise Value £58.05bn
Revenue £4.87bn
Position in Universe 163rd / 6827
Bullish
Bearish
Unlock ZTS Revenue
Momentum
Relative Strength (%)
1m +1.72%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -9.51%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
4,765 4,888 5,307 5,825 6,260 6,675 7,470 8,008 +7.0%
-10.5 +51.6 +35.0 +30.5 +9.7 +11.3 +25.4 +12.2
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, ZoetisInc revenues increased 7% to $6.68B. Net income increased9% to $1.64B. Revenues reflect US segment increase of 11%to $3.56B, International segment increase of 2% to $3.04B,The United States (U.S.) segment increase of 11% to $3.56B.Net income benefited from Restructuring charges decrease of76% to $8M (expense), Interest Capitalized increase of 31%to $17M (income).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for ZTS
Graphical History

Revenue

ZTS Revenue Unlock ZTS Revenue

Net Income

ZTS Net Income Unlock ZTS Revenue

Normalised EPS

ZTS Normalised EPS Unlock ZTS Revenue

PE Ratio Range

ZTS PE Ratio Range Unlock ZTS Revenue

Dividend Yield Range

ZTS Dividend Yield Range Unlock ZTS Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ZTS EPS Forecasts Unlock ZTS Revenue
Profile Summary

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a business, commercializing products across eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock) and dogs, cats and horses (collectively, companion animals), and within five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers. Its livestock products include Ceftiofur injectable line, Draxxin, Spectramast, Bovi-Shield line, Rispoval line, Suvaxyn/Fostera, Embrex devices and Lutalyse. Its companion animal products include Clavamox/Synulox, Convenia, ProHeart, Revolution/Stronghold, Apoquel, Cerenia and Rimadyl.

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
Incorporated July 25, 2012
Public Since February 1, 2013
No. of Shareholders: 1,748
No. of Employees: 11,300
Sector Healthcare
Industry Pharmaceuticals
Index S&P Composite 1500 , S&P 500 , S&P 500 Health Care (sector),
Exchange New York Stock Exchange
Shares in Issue 475,317,751
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ZTS Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ZTS
Upcoming Events for ZTS
Monday 19th April, 2021
Dividend For Z1TS34.SA - 0.3352 BRL
Tuesday 20th April, 2021
Dividend For ZTS.N - 0.2500 USD
Thursday 6th May, 2021
Q1 2021 Zoetis Inc Earnings Release
Thursday 6th May, 2021
Q1 2021 Zoetis Inc Earnings Call
Thursday 20th May, 2021
Zoetis Inc Annual Shareholders Meeting
Thursday 20th May, 2021 Estimate
Zoetis Inc Annual Shareholders Meeting
Wednesday 4th August, 2021 Estimate
Q2 2021 Zoetis Inc Earnings Release
Frequently Asked Questions for Zoetis Inc
What is the Zoetis Inc share price?

As of 09/04/21, shares in Zoetis Inc are trading at $159.85, giving the company a market capitalisation of £55.43bn. This share price information is delayed by 15 minutes.

How has the Zoetis Inc share price performed this year?

Shares in Zoetis Inc are currently trading at $159.85 and the price has moved by 24.16% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Zoetis Inc price has moved by -16.32% over the past year.

What are the analyst and broker recommendations for Zoetis Inc?

Of the analysts with advisory recommendations for Zoetis Inc, there are there are currently 7 "buy" , 5 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Zoetis Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Zoetis Inc next release its financial results?

Zoetis Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Zoetis Inc dividend yield?

The Zoetis Inc dividend yield is 0.5% based on the trailing twelve month period.

Does Zoetis Inc pay a dividend?

Last year, Zoetis Inc paid a total dividend of 0.8, and it currently has a trailing dividend yield of 0.5%. Looking ahead, shares in Zoetis Inc are due to go ex-dividend on 2021-04-20 and the next dividend pay date is 2021-06-01.

When does Zoetis Inc next pay dividends?

Zoetis Inc are due to go ex-dividend on 2021-04-20 and the next dividend pay date is 2021-06-01. The historic dividend yield on Zoetis Inc shares is currently 0.5%.

How do I buy Zoetis Inc shares?

To buy shares in Zoetis Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Zoetis Inc?

Shares in Zoetis Inc are currently trading at $159.85, giving the company a market capitalisation of £55.43bn.

Where are Zoetis Inc shares listed? Where are Zoetis Inc shares listed?

Here are the trading details for Zoetis Inc:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: ZTS
What kind of share is Zoetis Inc?

Based on an overall assessment of its quality, value and momentum, Zoetis Inc is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Zoetis Inc share price forecast 2021?

Shares in Zoetis Inc are currently priced at $159.85. At that level they are trading at 16.78% discount to the analyst consensus target price of 0.00.

Analysts covering Zoetis Inc currently have a consensus Earnings Per Share (EPS) forecast of 4.418 for the next financial year.

How can I tell whether the Zoetis Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zoetis Inc. Over the past six months, the relative strength of its shares against the market has been -16.65%. At the current price of $159.85, shares in Zoetis Inc are trading at 1.4% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Zoetis Inc PE Ratio?

The Zoetis Inc PE ratio based on its reported earnings over the past 12 months is 45.36. The shares are currently trading at $159.85.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Zoetis Inc?

Zoetis Inc's management team is headed by:

Juan Alaix - DRC
Frank D'amelio - IND
Heidi Chen - EVP
Catherine Knupp - EVP
Roxanne Lagano - CHO
Kristin Peck - CEO
Michael McCallister - NEC
Glenn David - CFO
Paul Bisaro - IND
Roman Trawicki - EVP
Antoinette Leatherberry - DRC
Who are the major shareholders of Zoetis Inc?

Here are the top five shareholders of Zoetis Inc based on the size of their shareholding:

The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 7.79% (37.0m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.93% (23.4m shares)
State Street Global Advisors (US) Investment Advisor/Hedge Fund
Percentage owned: 4.09% (19.4m shares)
State Farm Insurance Companies Insurance Company
Percentage owned: 3.8% (18.1m shares)
AllianceBernstein L.P. Investment Advisor/Hedge Fund
Percentage owned: 3.55% (16.8m shares)
Similar to ZTS
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.